C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 223/16 (2006.01) A61K 31/55 (2006.01) C07C 205/45 (2006.01) C07D 401/04 (2006.01) C07D 403/04 (2006.01) C07D 405/04 (2006.01) C07D 409/04 (2006.01) C07D 413/04 (2006.01) C07D 417/04 (2006.01) C07D 453/02 (2006.01) C07D 471/04 (2006.01) C07D 473/00 (2006.01) C07D 491/044 (2006.01)
Patent
CA 2098446
Abstract Methods of treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia and surgery, as well as treating neurodegenerative diseases including Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease and Down's syndrome, treating or preventing the adverse consequences of the hyperactivity of the excitatory amino acids, as well as treating anxiety, chronic pain, convulsions and inducing anesthesia are disclosed by administering to an animal in need of such treatment a substituted benzazepine which has high binding to the glycine receptor.
Huettner James E.
Keana John F. W.
Koroshetz Walter J.
Rees Alun H.
Swartz Kenton J.
Gowling Lafleur Henderson Llp
Huettner James E.
Keana John F. W.
Koroshetz Walter J.
Rees Alun H.
LandOfFree
2,5-dihydro-2,5-dioxo-1h-azepines and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,5-dihydro-2,5-dioxo-1h-azepines and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,5-dihydro-2,5-dioxo-1h-azepines and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1682738